Report ID |
16553 |
Drug Identification Number |
02230578 |
Brand name |
TWINRIX |
Common or Proper name |
Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine |
Company Name |
GLAXOSMITHKLINE INC |
Market Status |
MARKETED |
Active Ingredient(s) |
HEPATITIS A VACCINE, INACTIVATED
HEPATITIS B SURFACE ANTIGEN |
Strength(s) |
720UNIT
20MCG |
Dosage form(s) |
SUSPENSION |
Route of administration |
INTRAMUSCULAR |
Packaging size |
1's |
ATC code |
J07BC |
ATC description |
VIRAL VACCINES |
Reason for shortage |
Delay in shipping of the drug. |
Anticipated start date |
|
Actual start date |
2017-07-18 |
Estimated end date |
2017-12-07 |
Actual end date |
2017-12-04 |
Shortage status |
Resolved |
Updated date |
2017-12-06 |
Company comments |
Supply released July 10, 2017, August 9, 2017, October 3, 2017, and October 20, 2017 with limited quantity. Supply disruptions may be seen in the private market. Product under allocation. |
Health Canada comments |
|
Tier 3 Status |
No |
Company contact information |
1-800-387-7374 |